EtoposideAntineoplastic Agents, PhytogenicDrug Screening Assays, AntitumorAntineoplastic AgentsXenograft Model Antitumor AssaysAntineoplastic Combined Chemotherapy ProtocolsTopoisomerase II InhibitorsCisplatinIfosfamideDoxorubicinCell Line, TumorCarcinoma, Small CellDNA Topoisomerases, Type IIPodophyllotoxinAntibiotics, AntineoplasticTumor Cells, CulturedCyclophosphamideLeukemia P388VincristineLung NeoplasmsAmsacrineApoptosisDrug Administration ScheduleMice, NudeCarboplatinCombined Modality TherapyNeoplasms, ExperimentalNeoplasmsBiological ProductsNeoplasm TransplantationBleomycinDose-Response Relationship, DrugSarcoma 180Drug SynergismMelanoma, ExperimentalMolecular Sequence DataDrug Resistance, NeoplasmMice, Inbred BALB CCell SurvivalCytarabineTeniposideCamptothecinLeukemia L1210GerminomaCancer VaccinesAdministration, OralTreatment OutcomeAntigens, NeoplasmTopoisomerase I InhibitorsBase SequenceDNA DamageLeukopeniaMice, Inbred C57BLTopoisomerase InhibitorsMitoxantronePaclitaxelImmunotherapyInfusions, IntravenousNucleic Acid Synthesis InhibitorsCell ProliferationTransplantation, AutologousRemission InductionTopotecanAmino Acid SequenceDrug EvaluationTime FactorsCarmustineMolecular StructureTesticular NeoplasmsCell LineDrug ResistanceInhibitory Concentration 50Antibodies, MonoclonalSurvival AnalysisMice, SCIDHodgkin DiseaseTransplantation, HeterologousImmunotherapy, AdoptiveSurvival RateOrganophosphorus CompoundsCell DivisionRecombinant ProteinsNeoplasms, Germ Cell and EmbryonalRazoxaneLymphoma, Non-HodgkinKineticsEnediynesCell CycleDisease-Free SurvivalProdrugsDNAEnzyme InhibitorsDrug Resistance, MultipleHematologic DiseasesChromatography, High Pressure LiquidP-GlycoproteinVinblastineSalvage TherapyNeutropeniaFlow Cytometry